Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Compton LA, Murphy GF, Lian CG.

Dermatopathology (Basel). 2015 Apr 8;2(1):15-42. doi: 10.1159/000377698. eCollection 2015 Jan-Mar. Review.

2.

Primary Ewing Family of Tumors of the Jaw Has a Better Prognosis Compared to Tumors of Extragnathic Sites.

Owosho AA, Ko E, Rosenberg HI, Yom SK, Antonescu CR, Huryn JM, Estilo CL.

J Oral Maxillofac Surg. 2016 May;74(5):973-81. doi: 10.1016/j.joms.2015.10.029. Epub 2015 Nov 10.

3.

Immunohistochemical Markers of Soft Tissue Tumors: Pathologic Diagnosis, Genetic Contributions, and Therapeutic Options.

Parham DM.

Anal Chem Insights. 2015 Oct 29;10(Suppl 1):1-10. doi: 10.4137/ACI.S32730. eCollection 2015. Review.

4.
5.

Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.

Specht K, Sung YS, Zhang L, Richter GH, Fletcher CD, Antonescu CR.

Genes Chromosomes Cancer. 2014 Jul;53(7):622-33. doi: 10.1002/gcc.22172. Epub 2014 Apr 10.

6.

Fusion FISH imaging: single-molecule detection of gene fusion transcripts in situ.

Markey FB, Ruezinsky W, Tyagi S, Batish M.

PLoS One. 2014 Mar 27;9(3):e93488. doi: 10.1371/journal.pone.0093488. eCollection 2014.

7.

The small round blue cell tumors of the sinonasal area: histological and immunohistochemical findings.

J Ashraf M, Beigomi L, Azarpira N, Geramizadeh B, Khademi B, Hakimzadeh A, Abedi E.

Iran Red Crescent Med J. 2013 Jun;15(6):455-61. doi: 10.5812/ircmj.4735. Epub 2013 Jun 5.

8.

Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines.

May WA, Grigoryan RS, Keshelava N, Cabral DJ, Christensen LL, Jenabi J, Ji L, Triche TJ, Lawlor ER, Reynolds CP.

PLoS One. 2013 Dec 2;8(12):e80060. doi: 10.1371/journal.pone.0080060. eCollection 2013.

9.

Extraskeletal Ewing's sarcoma arising in the larynx.

Lynch MC, Baker A, Drabick JJ, Williams N, Goldenberg D.

Head Neck Pathol. 2014 Jun;8(2):225-8. doi: 10.1007/s12105-013-0492-6. Epub 2013 Sep 27.

10.

Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.

Tomlins SA, Palanisamy N, Brenner JC, Stall JN, Siddiqui J, Thomas DG, Lucas DR, Chinnaiyan AM, Kunju LP.

Am J Clin Pathol. 2013 Jun;139(6):771-9. doi: 10.1309/AJCPN4L1BMRQPEIT.

11.

Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma.

Smeets MF, Chan AC, Dagger S, Bradley CK, Wei A, Izon DJ.

PLoS One. 2013 May 7;8(5):e62346. doi: 10.1371/journal.pone.0062346. Print 2013.

12.

FNA diagnosis of CD99 positive neuroblastoma: A diagnostic dilemma.

Kaur G, Bakshi P, Verma K.

J Cytol. 2012 Apr;29(2):144-6. doi: 10.4103/0970-9371.97162.

13.

Guidelines for histopathological specimen examination and diagnostic reporting of primary bone tumours.

Mangham DC, Athanasou NA.

Clin Sarcoma Res. 2011 Jul 25;1(1):6. doi: 10.1186/2045-3329-1-6. Epub 2011 Jul 25.

14.

Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years.

Gamberi G, Cocchi S, Benini S, Magagnoli G, Morandi L, Kreshak J, Gambarotti M, Picci P, Zanella L, Alberghini M.

J Mol Diagn. 2011 May;13(3):313-24. doi: 10.1016/j.jmoldx.2011.01.004. Epub 2011 Mar 31.

15.

Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour.

Pinto A, Dickman P, Parham D.

Sarcoma. 2011;2011:856190. doi: 10.1155/2011/856190. Epub 2010 Oct 14.

16.

Pathology of Ewing's sarcoma/PNET: Current opinion and emerging concepts.

Desai SS, Jambhekar NA.

Indian J Orthop. 2010 Oct;44(4):363-8. doi: 10.4103/0019-5413.69304.

17.

Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification.

Cordes B, Williams MD, Tirado Y, Bell D, Rosenthal DI, Al-Dhahri SF, Hanna EY, El-Naggar AK.

Hum Pathol. 2009 Mar;40(3):283-92. doi: 10.1016/j.humpath.2008.07.019. Epub 2009 Jan 15.

18.

The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.

Gratzinger D, Zhao S, West R, Rouse RV, Vogel H, Gil EC, Levy R, Lossos IS, Natkunam Y.

Am J Clin Pathol. 2009 Feb;131(2):264-78. doi: 10.1309/AJCP5FP3NAXAXRJE.

19.

Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines.

Noguera R, Machado I, Piqueras M, Lopez-Guerrero JA, Navarro S, Mayordomo E, Pellin A, Llombart-Bosch A.

Diagn Pathol. 2008 Jul 15;3 Suppl 1:S27. doi: 10.1186/1746-1596-3-S1-S27.

20.

Ewing family of tumours involving the vulva and vagina: report of a series of four cases.

McCluggage WG, Sumathi VP, Nucci MR, Hirsch M, Dal Cin P, Wells M, Flanagan AM, Fisher C.

J Clin Pathol. 2007 Jun;60(6):674-80. Review.

Items per page

Supplemental Content

Write to the Help Desk